Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria

Clinical and Vaccine Immunology

Volumn 14, Issue 10, 2007, Pages 1296-1301

  Delpino, M Victoria ^a   Estein, Silvia M ^b   Fossati, Carlos A ^a   Baldi, Pablo C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; BRUCELLA MELITENSIS VACCINE; BRUCELLA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; LIVE VACCINE; MESORHIZOBIUM LOTI VACCINE; NONPATHOGENIC ALPHAPROTEOBACTERIA VACCINE; OCHROBACTRUM ANTHROPI VACCINE; RHIZOBIUM RADIOBACTER VACCINE; SINORHIZOBIUM MELILOTI VACCINE; UNCLASSIFIED DRUG;

ALPHAPROTEOBACTERIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIUM CULTURE; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CROSS REACTION; IMMUNIZATION; INFECTION PREVENTION; MESORHIZOBIUM; MOUSE; NONHUMAN; OCHROBACTRUM ANTHROPI; PATHOGENICITY; PRIORITY JOURNAL; RHIZOBIUM RADIOBACTER; SINORHIZOBIUM MELILOTI;

ANIMALS; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; HEAT; MICE; OCHROBACTRUM ANTHROPI; RHIZOBIUM RADIOBACTER; SINORHIZOBIUM MELILOTI; VACCINES, INACTIVATED;

EID: 35548987536     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00459-06     Document Type: Article

References (31)

1. Al-Mariri, A., A. Tibor, P. Mertens, X. De Bolle, P. Michel, J. Godefroid, K. Walravens, and J. J. Letesson. 2001. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect. Immun. 69:4816-4822.
2. Alnor, D., N. Frimodt-Moller, F. Espersen, and W. Frederiksen. 1994. Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin. Infect. Dis. 18:914-920.
3. Amaya, R. A., and M. S. Edwards. 2003. Agrobacterium radiobacter bacteremia in pediatric patients: case report and review. Pediatr. Infect. Dis. J. 22:183-186.
4. Ashford, D. A., J. di Pietra, J. Lingappa, C. Woods, H. Noll, B. Neville, R. Weyant, S. L. Bragg, R. A. Spiegel, J. Tappero, and B. A. Perkins. 2004. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22:3435-3439.
5. Bardenstein, S., M. Mandelboim, T. A. Ficht, M. Baum, and M. Banai. 2002. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene J. Clin. Microbiol. 40:1475-1480.
6. Blasco, J. M., and R. Diaz. 1993. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 342:805.
7. Bogard, W. C., Jr., D. L. Dunn, K. Abernethy, C. Kilgarriff, and P. C. Kung. 1987. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. Infect. Immun. 55:899-908.
8. Bosseray, N., and M. Plommet. 1983. A laboratory reference vaccine to titrate immunogenic activity of anti-brucella vaccines in mice. Ann. Rech. Vet. 14:163-168.
9. Cassataro, J., C. A. Velikovsky, S. de la Barrera, S. M. Estein, L. Bruno, R. Bowden, K. A. Pasquevich, C. A. Fossati, and G. H. Giambartolomei. 2005. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect. Immun. 73:6537-6546.
10. Cassataro, J., C. A. Velikovsky, G. H. Giambartolomei, S. Estein, L. Bruno, A. Cloeckaert, R. A. Bowden, M. Spitz, and C. A. Fossati. 2002. Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine 20:1660-1669.
11. Centers for Disease Control and Prevention and National Institutes of Health. 1999. Biosafety in microbiological and biomedical laboratories, 4th ed. U.S. Department of Health and Human Services, Washington, DC.
12. Delpino, M. V., C. A. Fossati, and P. C. Baldi. 2004. Occurrence and potential diagnostic applications of serological cross-reactivities between Brucella and other alpha-proteobacteria. Clin. Diagn. Lab. Immunol. 11:868-873.
13. DelVecchio, V. G., V. Kapatral, R. J. Redkar, G. Patra, C. Mujer, T. Los, N. Ivanova, I. Anderson, A. Bhattacharyya, A. Lykidis, G. Reznik, L. Jablonski, N. Larsen, M. D'Souza, A. Bernal, M. Mazur, E. Goltsman, E. Selkov, P. H. Elzer, S. Hagius, D. O'Callaghan, J. J. Letesson, R. Haselkorn, N. Kyrpides, and R. Overbeek. 2002. The genome of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA 99:443-448.
14. Deqiu, S., X. Donglou, and Y. Jiming. 2002. Epidemiology and control of brucellosis in China. Vet. Microbiol. 90:165-182.
15. Estein, S. M., J. Cassataro, N. Vizcaíno, M. S. Zygmunt, A. Cloeckaert, and R. A. Bowden. 2003. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes Infect. 5:85-93.
16. Guilloteau, L. A., K. Laroucau, N. Vizcaino, I. Jacques, and G. Dubray. 1999. Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice. Vaccine 17:353-361.
17. Halling, S. M., B. D. Peterson-Burch, B. J. Bricker, R. L. Zuerner, Z. Qing, L. L. Li, V. Kapur, D. P. Alt, and S. C. Olsen. 2005. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J. Bacteriol. 187:2715-2726.
18. He, Y., R. Vemulapalli, and G. G. Schurig. 2002. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type. Infect. Immun. 70:2535-2543.
19. Hirsch, A. M., M. R. Lum, and J. A. Downie. 2001. What makes the rhizobia-legume symbiosis so special? Plant Physiol. 127:1484-1492.
20. Luo, D., B. Ni, P. Li, W. Shi, S. Zhang, Y. Han, L. Mao, Y. He, Y. Wu, and X. Wang. 2006. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect. Immun. 74:2734-2741.
21. Mahmood, M. S., A. R. Sarwari, M. A. Khan, Z. Sophie, E. Khan, and S. Sami. 2000. Infective endocarditis and septic embolization with Ochrobactrum anthropi: case report and review of literature. J. Infect. 40:287-290.
22. Marks, M. I., E. J. Ziegler, H. Douglas, L. B. Corbeil, and A. I. Braude. 1982. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J. Clin. Investig. 69:742-749.
23. McCabe, W. R., A. DeMaria, and M. Johns. 1980. Potential use of shared antigens for immunization against gram-negative bacillary infections. Prog. Clin. Biol. Res. 47:107-117.
24. Moreno, E., A. Cloeckaert, and I. Moriyón. 2002. Brucella evolution and taxonomy. Vet. Microbiol. 90:209-227.
25. Paulsen, I. T., R. Seshadri, K. E. Nelson, J. A. Eisen, J. F. Heidelberg, T. D. Read, R. J. Dodson, L. Umayam, L. M. Brinkac, M. J. Beanan, S. C. Daugherty, R. T. Deboy, A. S. Durkin, J. F. Kolonay, R. Madupu, W. C. Nelson, B. Ayodeji, M. Kraul, J. Shetty, J. Malek, S. E. Van Aken, S. Riedmuller, H. Tettelin, S. R. Gill, O. White, S. L. Salzberg, D. L. Hoover, L. E. Lindler, S. M. Halling, S. M. Boyle, and C. M. Fraser. 2002. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc. Natl. Acad. Sci. USA 99:13148-13153.
26. Penner, J. L., and G. R. Whiteley. 1978. Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria. Infect. Immun. 20:347-351.
27. Pivnick, H., H. Worton, D. L. Smith, and D. Barnum. 1966. Infection of veterinarians in Ontario by Brucella abortus strain 19. Can. J. Public Health 57:225-231.
28. Stanislavsky, E. S., E. V. Kholodkova, T. A. Makarenko, and M. V. Sukhachevskaya. 1995. Mouse protection induced by Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re-mutant and Escherichia coli O14. FEMS Immunol. Med. Microbiol. 11:81-86.
29. Tzfira, T., and V. Citovsky. 2002. Partners-in-infection: host proteins involved in the transformation of plant cells by Agrobacterium. Trends Cell Biol. 12:121-129.
30. Velasco, J., R. Diaz, M. J. Grillo, M. Barberan, C. Marin, J. M. Blasco, and I. Moriyon. 1997. Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp. Clin. Diagn. Lab. Immunol. 4:279-284.
31. Velikovsky, C. A., F. A. Goldbaum, J. Cassataro, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and G. H. Giambartolomei. 2003. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect. Immun. 71:5750-5755.